Demographic features of 40 patients with carpometacarpal joint osteoarthritis, randomly assigned to receive placebo or steroid injection to the symptomatic thumb base joint
| Clinical feature | Placebo | Steroid |
|---|---|---|
| Data are numbers or median (95% confidence interval) unless stated otherwise. The Wilcoxon signed rank was used to assess differences between the groups. | ||
| CMC, carpometacarpal; VAS, visual analogue score. | ||
| Age (years), mean (range) | 59.3 (46 to 69) | 60.6 (41 to 71) |
| Mean duration of symptoms (years) | 8.2 | 7.4 |
| Female/male | 17/3 | 19/1 |
| Family history of hand osteoarthritis | 14 | 14 |
| Dominant hand injected | 14 | 16 |
| Bilateral symptoms | 6 | 4 |
| Nodal osteoarthritis present | 13 | 16 |
| VAS | 56 (50 to 78) | 52 (40 to 72) |
| Joint tenderness | 2 (1 to 2) | 2 (1 to 3) |
| Physician’s global assessment | 4 (3 to 4) | 3 (2 to 4) |
| Patient’s global assessment | 4 (3 to 4) | 3 (2 to 4) |
| Joint stiffness | 15 (10 to 30) | 20 (0 to 30) |
| CMC joint space narrowing | 3 (2 to 4) | 3 (2 to 4) |
| CMC osteophyte grade | 3 (2 to 4) | 3 (2 to 4) |